Alnylam News

Alnylam TTR Franchise Surges 59%, Supernus Posts Record $226.8M Revenue, BridgeBio's Attruby Up 134% in Q3 Pharma Earnings

Alnylam Pharmaceuticals' TTR franchise revenue surged 59% on strong AMVUTTRA demand, with total product revenue growing 52% in Q3 2026.

Oct 31, 2026